Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maria

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
Cadernos De Saude Publica|January 8, 1999
[Rabies epizootic in the urban area of Ribeirão Preto, São Paulo, Brazil]A D Passos, A A Castro e Silva, A H Ferreira, et al.
Scientific Reports|January 3, 2025
SVM directed machine learning classifier for human action recognition networkDharmanna Lamani, Pramod Kumar, A Bhagyalakshmi, et al.
Revista Espanola De Anestesiologia Y Reanimacion|June 18, 2004
[PiCCO monitoring of 4 critically ill patients]J Maria Jiménez Vizuete, M Cortiñas Sáenz, R Peyró García, et al.
Actas Urologicas Espanolas|July 14, 2004
[Carcinosarcoma of the bladder: report of our cases and review of the literature]E Argüelles Salido, P Travado Soria, Maria P Pérez Espejo, et al.
Frontiers in Immunology|September 19, 2017
Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell FunctionGuillaume Fonteneau, Claire Bony, Radjiv Goulabchand, et al.
Nanotechnology|October 6, 2009
Nanopost plasmonic crystalsT T Truong, J Maria, J Yao, et al.
Frontiers in Immunology|November 21, 2018
Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem CellsAlexandre T J Maria, Karine Toupet, Marie Maumus, et al.
ESMO Open|November 21, 2023
Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors: a real-world retrospective cohort studyJ Colard-Thomas, C Manceron, C Duflos, et al.
Oncology|March 1, 1997
Study of the DNA content by flow cytometry and proliferation in 281 brain tumorsR García, A Bueno, S Castañon, et al.
Frontiers in Immunology|January 10, 2019
iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic SclerosisAlexandre T J Maria, Pauline Rozier, Guillaume Fonteneau, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
Cadernos De Saude Publica|January 8, 1999
[Rabies epizootic in the urban area of Ribeirão Preto, São Paulo, Brazil]A D Passos, A A Castro e Silva, A H Ferreira, et al.
Scientific Reports|January 3, 2025
SVM directed machine learning classifier for human action recognition networkDharmanna Lamani, Pramod Kumar, A Bhagyalakshmi, et al.
Revista Espanola De Anestesiologia Y Reanimacion|June 18, 2004
[PiCCO monitoring of 4 critically ill patients]J Maria Jiménez Vizuete, M Cortiñas Sáenz, R Peyró García, et al.
Actas Urologicas Espanolas|July 14, 2004
[Carcinosarcoma of the bladder: report of our cases and review of the literature]E Argüelles Salido, P Travado Soria, Maria P Pérez Espejo, et al.
Frontiers in Immunology|September 19, 2017
Serum-Mediated Oxidative Stress from Systemic Sclerosis Patients Affects Mesenchymal Stem Cell FunctionGuillaume Fonteneau, Claire Bony, Radjiv Goulabchand, et al.
Nanotechnology|October 6, 2009
Nanopost plasmonic crystalsT T Truong, J Maria, J Yao, et al.
Frontiers in Immunology|November 21, 2018
Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem CellsAlexandre T J Maria, Karine Toupet, Marie Maumus, et al.
ESMO Open|November 21, 2023
Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors: a real-world retrospective cohort studyJ Colard-Thomas, C Manceron, C Duflos, et al.
Oncology|March 1, 1997
Study of the DNA content by flow cytometry and proliferation in 281 brain tumorsR García, A Bueno, S Castañon, et al.
Frontiers in Immunology|January 10, 2019
iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic SclerosisAlexandre T J Maria, Pauline Rozier, Guillaume Fonteneau, et al.
Pageof 17